Convertible Note

We are Rolling the Dice on this One…

Next Investors Oct 13, 2020

Long term Creso Pharma (ASX: CPH) shareholders have had a rough ride in the last 12 months. Last week the $20M capped CPH raised circa A$9M at $0.0291 per share, finally extinguishing the company’s debt and ridding the company of major con note holders that were hampering any share price appreciation.

MyFiziq increases stake in BCT and improves chances of NASDAQ listing

Finfeed Archived Jul 20, 2020

There have been some important developments in MyFiziq's (ASX: MYQ) joint venture arrangement with Body Composition Technologies.